Figure 2.
Figure 2. Role of endogenous LTs and their receptors in AM killing of opsonized K pneumoniae. (A) AMs from WT or 5-LO KO mice were infected with 50:1 K pneumoniae for 30 minutes, incubated without or with LT mixture (LTB4, 1 nM; LTC4 and LTD4, 100 nM each), and bacterial killing was then assessed. (B) Rat AMs were pretreated with vehicle control, the 5-LO inhibitor AA-861 (10 μM), or the FLAP inhibitor MK-886 (1 μM) for 15 minutes before the addition of opsonized K pneumoniae. Thirty minutes after infection, drugs were added back with or without LT mixture, and bacterial killing was assessed. (C) Rat AMs were treated with the LTB4 receptor antagonist CP105696 (10 μM) or the cysLT receptor antagonist MK571 (10 μM) or vehicle control for 15 minutes before the addition of opsonized K pneumoniae. Thirty minutes after infection, the antagonists were added back with or without 1 nM LTB4 or LTC4 plus LTD4 (100 nM each). Microbicidal activity was assessed. Data are expressed as mean ± SE percentage of survival of ingested bacteria of quadruplicate values from 1 of 4 representative experiments. *P < .05 compared with untreated control by ANOVA. #P < .05 versus AA-861, MK 886, or 5-LO KO group by ANOVA.

Role of endogenous LTs and their receptors in AM killing of opsonized K pneumoniae. (A) AMs from WT or 5-LO KO mice were infected with 50:1 K pneumoniae for 30 minutes, incubated without or with LT mixture (LTB4, 1 nM; LTC4 and LTD4, 100 nM each), and bacterial killing was then assessed. (B) Rat AMs were pretreated with vehicle control, the 5-LO inhibitor AA-861 (10 μM), or the FLAP inhibitor MK-886 (1 μM) for 15 minutes before the addition of opsonized K pneumoniae. Thirty minutes after infection, drugs were added back with or without LT mixture, and bacterial killing was assessed. (C) Rat AMs were treated with the LTB4 receptor antagonist CP105696 (10 μM) or the cysLT receptor antagonist MK571 (10 μM) or vehicle control for 15 minutes before the addition of opsonized K pneumoniae. Thirty minutes after infection, the antagonists were added back with or without 1 nM LTB4 or LTC4 plus LTD4 (100 nM each). Microbicidal activity was assessed. Data are expressed as mean ± SE percentage of survival of ingested bacteria of quadruplicate values from 1 of 4 representative experiments. *P < .05 compared with untreated control by ANOVA. #P < .05 versus AA-861, MK 886, or 5-LO KO group by ANOVA.

Close Modal

or Create an Account

Close Modal
Close Modal